Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;13(6):546-556.
doi: 10.4103/1735-5362.245966.

Effects of thyroid-stimulating hormone on adhesion molecules and pro-inflammatory cytokines secretion in human umbilical vein endothelial cells

Affiliations

Effects of thyroid-stimulating hormone on adhesion molecules and pro-inflammatory cytokines secretion in human umbilical vein endothelial cells

Attabak Toofani Milani et al. Res Pharm Sci. 2018 Dec.

Abstract

Atherosclerosis is a multifactorial disorder, which affects the arterial wall. It has been reported that, hypothyroidism and thyroid hormone deficiency are related to cardiovascular disorders. Also, endothelial dysfunction plays an essential role in the development of atherosclerosis. We aimed to evaluate the effects of thyroid-stimulating hormone (TSH) on pro-inflammatory tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), angiogenic vascular endothelial growth factor (VEGF) and leukocyte adhesion, intercellular adhesion molecule 1 (ICAM-1) and E-selectin in human umbilical vein endothelial cells (HUVECs). In this study, HUVEC cells were treated with 1 and 2 μM of TSH in different treatment times. The gene and protein expression of ICAM-1, VEGF, and E-selectin were performed by real-time polymerase chain reaction and western blotting, respectively. Likewise, TNF-α and IL-6 protein levels were determined by the ELISA method. VEGF, ICAM-1, and E-selectin as endothelial dysfunction markers and also, TNF-α and IL-6 as pro-inflammatory cytokines were detectable in HUVEC. Besides, the results of this study revealed that TSH treatment down-regulates TNF-α and IL-6. Evaluating the gene and protein expression data revealed the upregulation of ICAM-1, E-selectin, and VEGF in TSH treated cases in different periods of exposure. Considering the multiple actions of TSH, it could be concluded that TSH plays a controversial role in atherogenesis by anti-inflammatory effects and on the other side, angiogenesis and leukocyte adhesion induction which is related to vascular cell proliferation.

Keywords: E-selectin; HUVEC; ICAM-1; TNF-α; Thyrotropin; VEGF.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Down regulation of tumor necrosis factor-α (TNF-α) level in HUVECs by thyroid-stimulating hormone (TSH) exposure. After treatments with TSH (1 and 2 μM) for 12, 24, and 48 h, protein expression evaluated by ELISA method. * Indicates significant differences (P< 0.05) compared to control group. Data are presented as mean ± SD values derived from three independent experiments.
Fig. 2
Fig. 2
Down regulation of interleukin-6 (IL-6) levels in HUVECs by thyroid-stimulating hormone (TSH) exposure. After treatments with TSH (1 and 2 μM) for 12, 24, and 48 h, protein expression evaluated by ELISA method. * Indicates significant differences (P< 0.05) compared to control group. Data presented as mean ± SD values derived from three independent experiments.
Fig. 3
Fig. 3
mRNA levels of E-selectin in HUVECs cells treated by thyroid-stimulating hormone (TSH) (1 and 2 μM) for (A) 24 h and (B) 48 h exposure times. Data presented as mean fold change ± SD values derived from three independent experiments. *P< 0.01.
Fig. 4
Fig. 4
mRNA levels of intercellular adhesion molecule 1 (ICAM-1) in HUVECs cells treated by thyroid-stimulating hormone (TSH) (1 and 2 μM) for (A) 24 h and (B) 48 h exposure times. Data presented as mean fold change ± SD values derived from three independent experiments.*P< 0.01.
Fig. 5
Fig. 5
mRNA levels of vascular endothelial growth factor (VEGF) in HUVECs cells treated by thyroid-stimulating hormone (TSH) (1 and 2 μM) for (A) 24 h and (B) 48 h exposure times. Data presented as mean fold change ± SD values derived from three independent experiments.*P< 0.05, **P< 0.01.
Fig. 6
Fig. 6
Prortein detection for evaluation of E-selectin expression performed using western blotting technique. (A) Protein expression levels of E-selectin in HUVECs cells treated by thyroid-stimulating hormone (TSH) (1 and 2 μM) for 6 and 24 h and (B) TSH treatment significantly increased relative expression of E-selectin. For analysis protein's bands densities, Image J software was used to analyze the densities. Each protein (in one repeat) bands normalized to β-actin bands.
Fig. 7
Fig. 7
Prortein detection for evaluation of E-selectin expression performed using western blotting technique. (A) Protein expression levels of E-selectin in HUVECs cells treated by thyroid-stimulating hormone (TSH) (1 and 2 μM) for 6 and 24 hand (B) TSH treatment significantly increased relative expression of E-selectin. For analysis protein's bands densities, Image J software was used to analyze the densities. Each protein (in one repeat) bands normalized to β-actin bands.

Similar articles

Cited by

References

    1. Tian L, Zhang L, Liu J, Guo T, Gao C, Ni J. Effects of TSH on the function of human umbilical vein endothelial cells. J Clin Mol Endocrinol. 2014;52(2):215–222. - PubMed
    1. Coceani M, Iervasi G, Pingitore A, Carpeggiani C, L'Abbate A. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol. 2009;32(7):380–385. - PMC - PubMed
    1. Mayer O, Jr, Šimon J, Filipovský J, Plášková M, Pikner R. Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc Health Risk Manag. 2006;2(4):499–506. - PMC - PubMed
    1. Cai Y, Manio MM, Leung GP, Xu A, Tang EH, Vanhoutte PM. Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries. Eur J Pharmacol. 2015;747:18–28. - PubMed
    1. Antunes TT, Gagnon A, Bell A, Sorisky A. Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase a pathway. Obes Res. 2005;13(12):2066–2071. - PubMed